New Ethical Guidelines For Japan Clinical Research Proposed
This article was originally published in PharmAsia News
Executive Summary
In response to the problems that began with discrepancies in the clinical trials regarding the Novartis drug Diovan (valsartan), MHLW Japan proposed new ethical guidelines for research institutions on May 1.